Long-term observation of the perinuclear anti-neutrophil cytoplasmic antibody status in ulcerative colitis patients

Scandinavian Journal of Gastroenterology

Volumn 33, Issue 2, 1998, Pages 170-173

  Vecchi, M ^a,b   Bianchi, M B ^a   Calabresi, C ^a   Meucci, G ^a   Tatarella, M ^a   De Franchis, R ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b Istituto di Medicina Interna   (Italy)

Author keywords

Anti neutrophil cytoplasmic antibodies; Autoantibodies; Inflammatory bowel disease; Ulcerative colitis

Indexed keywords

AUTOANTIBODY; MARKER; NEUTROPHIL CYTOPLASMIC ANTIBODY;

ADULT; ANTIBODY TITER; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; FEMALE; FOLLOW UP; HUMAN; IMMUNOFLUORESCENCE; MALE; PRIORITY JOURNAL; ULCERATIVE COLITIS;

ADOLESCENT; ADULT; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; COLITIS, ULCERATIVE; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED;

EID: 0031932214     PISSN: 00365521     EISSN: None     Source Type: Journal    
DOI: 10.1080/00365529850166905     Document Type: Article

References (21)

1. Saxon A, Shanahan F, Landers C, Ganz T, Targan S. A distinct subset of anti-neutrophil cytoplasmic antibodies is associated with inflammatory bowel disease. J Allergy Clin Immunol 1990;86:202-10.
2. Duerr RH, Targan S, Landers C, Sutherland LR, Shanahan F. Anti-neutrophil cytoplasmic antibodies in ulcerative colitis. Comparison with other colitides/diarrheal ilnesses. Gastroenterology 1991;100:1590-96.
3. Colombel JF, Reumaux D, Duthilleul P, Noel LH, Gower-Rousseau C, Paris JC, et al. Anti-neutrophil cytoplasmic autoantibodies in inflammatory bowel diseases. Gastroenterol Clin Biol 1992;16:656-60.
4. Oudkerk Pool M, Ellerbroek PM, Ridwan BU, Goldschmeding R, von Blomberg BM, Pena AS, et al. Serum anti-neutrophil cytoplasmic autoantibodies in inflammatory bowel disease are mainly associated with ulcerative colitis: a correlation study between perinuclear antineutrophil cytoplasmic autoantibodies and clinical parameters, medical, and surgical treatment. Gut 1993;34:46-50.
5. Cambridge G, Rampton DS. Stevens TR, McCarthy DA, Kamm M, Leaker B. Anti-neutrophil antibodies in inflammatory bowel disease: prevalence and diagnostic role. Gut 1992;33:668-74.
6. Seibold F, Weber P, Klein R. Berg PA, Wiedmann KH. Clinical significance of antibodies against neutrophils in patients with inflammatory bowel disease and primary sclerosing cholangitis. Gut 1992;33:657-62.
7. Rump JA, Scholmerich J, Gross V, Roth M, Helfesrieder R, Rautmann A, et al. A new type of perinuclear anti-neutrophil cytoplasmic antibody (p-ANCA) in active ulcerative colitis but not in Crohn's disease. Immunobiology 1990;181:406-13.
8. Hardarson S, Labrecque DR, Mitros FA, Neil GA, Goeken JA. Anti-neutrophil cytoplasmic antibody in inflammatory bowel and hepatobiliary diseases: high prevalence in ulcerative colitis. primary sclerosing cholangitis and autoimmune hepatitis. Am J Clin Pathol 1993;99:277-81.
9. Patel RT, Pall AA, Stokes R, Birch D, Hail C, Adu D, et al. Autoantibody prevalence and association in inflammatory bowel disease. Eur J Gastroenterol Hepatol 1994;6:705-9.
10. Vecchi M, Bianchi MB, Sinico RA, Radice A, Meucci G. Torgano G, et al. Antibodies to neutrophil cytoplasm in Italian patients with ulcerative colitis: sensitivity, specificity and recognition of putative antigens. Digestion 1994;55:34-9.
11. Shanahan F, Duerr RH, Rotter JI, Yang H, Sutherland L, McElree C, et al. Neutrophil autoantibodies in ulcerative colitis: familial aggregation and genetic heterogeneity. Gastroenterology 1992;103:456-61.
12. Seibold F, Slametschka D, Gregor M, Weber P. Neutrophil autoantibodies: a genetic marker in primary sclerosing cholangitis and ulcerative colitis. Gastroenterology 1994;107:532-6.
13. Lee JCW, Lennard-Jones JE, Cambridge G. Antineutrophil antibodies in familial inflammatory bowel disease. Gastroenterology 1995;108:428-33.
14. Reumaux D, Delecourt L, Colombel JF, Noel LH, Duthilleul P, Cortot A. Anti-neutrophil cytoplasmic autoantibodies in realtives of patients with ulcerative colitis [letter]. Gastroenterology 1992;103:1706.
15. Yang P, Jarnerot G, Danielsson D, Tysk C. Lindberg E. p-ANCA in monozygotic twins with inflammatory bowel disease. Gut 1995;36:887-90.
16. Sandborn WJ, Landers CJ, Tremaine WJ, Targan SR. Association of antineutrophil cytoplasmic antibodies with resistance to treatment of left-sided ulcerative colitis: results of a pilot study. Mayo Clin Proc 1996;71:431-6.
17. Vecchi M, Gionchetti P, Bianchi MB, Belluzzi A, Meucci G, Campieri M, et al. p-ANCA and development of pouchitis in ulcerative colitis patients after proctocolectomy and ileoanal pouch anastomosis [letter]. Lancet 1994;344:886-7.
18. Sandborn WJ, Landers CJ, Tremaine WJ, Targan SR. Antineutrophil cytoplasmic antibody correlates with chronic pouchitis after ileal pouch-anal anastomosis. Am J Gastroenterol 1995;90:740-7.
19. Reumaux D, Colombel JF, Heresbach D, Duclos B, Chaussade S, Belaiche J, et al. Antineutrophil cytoplasmic auto-antibodies in sera from patients after proctocolectomy for ulcerative colitis [abstract]. Gastroenterology 1993;104 Suppl:A769.
20. Rotter JI, Toyoda H, Landers C, Tyan D, McElree CK, Targan SR. Ulcerative colitis: a genetically heterogeneous disorder defined by genetic (HLA class II) and subclinical (antineutrophil cytoplasmic antibodies) markers. J Clin Invest 1993;92:1080-4.
21. Monteleone R, Marasco T, Parrello P, Doldo C, Cavaliere F, Luzza F, et al. Variation of p-ANCA over time in patients with ulcerative colitis [abstract]. Ital J Gastroenterol 1996;28 Suppl 2:176.